Skip to main content

Articles

Page 4 of 14

  1. Canada has experienced a distinctly bifurcated pattern of (strong) opioid utilization post-2000, with multifold increases rendering it one of the world’s highest opioid consumption rates, followed by subsequen...

    Authors: Wayne Jones, Ridhwana Kaoser, David Rudoler and Benedikt Fischer
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:27
    Content type: Research Published on:

  2. People with weakened immune systems may not develop adequate protection after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may improve the level of protection against Covid-19.

    Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, Mustafa Habeb and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:26
    Content type: Research Published on:

  4. Community pharmacies are widely distributed in the United Arab Emirates where community pharmacists’ (CPs’) perspectives on provision of extended community pharmacy services (ECPS) is not known. This study ass...

    Authors: Subish Palaian, Muaed Alomar, Nageeb Hassan and Fatima Boura
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:24
    Content type: Research Published on:

  5. Globally, hypertension is a major public health problem and a strong predictor of cardiovascular disease complications. To reduce and prevent complications from hypertension, it is important to adapt self-care...

    Authors: Tsegaye Melaku, Bodena Bayisa, Helen Fekeremaryam, Alemayehu Feyissa and Alemayehu Gutasa
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:23
    Content type: Research Published on:

  6. Harm with inappropriate and irrational use of medications is a global challenge. The need for and patient access to medicines optimisation services is apparent globally and amplified in India due to multiple r...

    Authors: Mansi Doshi, Minesh Parbat, Vibhu Paudyal and John Marriott
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:22
    Content type: Commentary Published on:

  7. Community pharmacists (CPs) are one of the frontline healthcare workers (HCWs) working diligently to provide much-needed services during the COVID-19 pandemic. Burnout was one of the detrimental outcomes of th...

    Authors: Dalal Youssef, Linda Abou-Abbas and Janet Youssef
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:21
    Content type: Research Published on:

  8. In 2019, more than $34.5 billion was spent on prescription drugs in Canada. However, little is known about the distribution of this spending across medications and settings (outpatient and inpatient) over time...

    Authors: Mark Hofmeister, Ashwinie Sivakumar, Fiona Clement, Kaleen N. Hayes, Michael Law, Jason R. Guertin, Heather L. Neville and Mina Tadrous
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:20
    Content type: Research Published on:

  9. Adverse drug event (ADE) reporting is a significant process to increase consumer care and consumer safety associated with the use of medicines. An in-depth investigation into low ADE reporting by consumers and...

    Authors: Tanattha Kitisopee, Jirunya Assanee, Bernard A. Sorofman and Suntaree Watcharadmrongkun
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:19
    Content type: Research Published on:

  10. Pharmaceutical advertising is not only considered a key factor in the successful launch of pharmaceutical products, but is also an important source of public health information with a significant impact on con...

    Authors: Nazila Yousefi, Zahra Sharif, Fateme Chahian, Tayebe Mombeini and Farzad Peiravian
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:18
    Content type: Research Published on:

  11. Medicines of poor quality are currently prevailing problems undermining the quality of health care services in veterinary and human medicine. In this study, physico-chemical quality of veterinary medicines was...

    Authors: Belachew Tefera, Belachew Bacha, Sileshi Belew, Raffaella Ravinetto, Tenaw Andualem, Zerihun Abegaz, Ayalew Zelelew, Gudeta Uma, Tadese Setegn, Abdisa Hunduma, Dinsefa Jemal, Diriba Daba and Bizuayehu Belete
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:17
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2022 15:41

  12. Successful mass vaccination programmes are public health achievements of the contemporary world. While pharmaceutical companies are actively developing new vaccines, and demonstrating results of effectiveness ...

    Authors: Mathumalar Loganathan Fahrni, Intan An-Nisaa’ Ismail, Dalia Mohammed Refi, Ahmad Almeman, Norliana Che Yaakob, Kamaliah Md Saman, Nur Farhani Mansor, Noorasmah Noordin and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:16
    Content type: Review Published on:

  13. To determine how additional explanatory text (context) about drug side effects in a patient medication information handout affected comprehension and perceptions of risk and efficacy.

    Authors: Bridget Kelly, Amie O’Donoghue, Sarah Parvanta, Vanessa Boudewyns, Oluwamurewa Oguntimein, Carla Bann, Sue West, Janice Tzeng, Caroline Chandler, Gabriel Madson and Lauren McCormack
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:15
    Content type: Research Published on:

  14. The health supply chain system is essential for the optimum performance of the healthcare system. Despite increased investments in the health supply chain system, access to quality Essential Medicines and Heal...

    Authors: Eric Lugada, Henry Komakech, Irene Ochola, Shiela Mwebaze, Martin Olowo Oteba and Denis Okidi Ladwar
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:14
    Content type: Review Published on:

  15. The consistency and the quality of medicine labels are sought through the regulatory frameworks. This study aims at investigating the secondary labels of medicines based on the labeling regulations and guideli...

    Authors: Manori Jayasinghe, Thotawaththage Loshadhi Indunika Srilal, Deweni Guruge Pathmila Prasadi, Wickramasinghe Senanayakege Sachini Madushika, Samanda Marakkala Dileka Udyani Silva and Sewwandi Subasinghe
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:13
    Content type: Research Published on:

  16. The improper disposal of unused drugs can harm the environment and living beings. Programs such as drug take-back bins encourage people to dispose of unused medication at designated locations have increased. U...

    Authors: Tamara Vehige Calise, Sarah Levin Martin and Chloe Wingerter
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:12
    Content type: Research Published on:

  17. Currently, the private healthcare sector's role in healthcare delivery is growing in Ethiopia. However, there are limited studies on private healthcare sector drug use patterns. This study aimed to evaluate th...

    Authors: Getahun Asmamaw, Nahu Ejigu, Dinksew Tewihubo and Wondim Ayenew
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:11
    Content type: Research Published on:

  18. Multi- criteria decision analysis (MCDA) can assist policymakers in objectively choosing between alternative therapeutic options based on multiple value attributes. Our aim was to create an MCDA tool for the n...

    Authors: Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal, Mariam Eldebeiky, Hanaa Amer, Shimaa Akeel, Ahmad Morsy, Amira Amin, Amr Shafik, Sherif Abaza and Zoltán Kaló
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:10
    Content type: Research Published on:

  20. Community pharmacists are among the most accessible healthcare professionals and are likely to experience the full brunt of public health crises. In Lebanon, the COVID-19 pandemic, added to a severe economic m...

    Authors: Mohamad Alameddine, Karen Bou-Karroum and Mohamad Ali Hijazi
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:8
    Content type: Research Published on:

  21. Delays in producing discharge prescriptions have hindered the provision of bedside dispensing services (BEDISC) that enable medication reconciliation and pharmaceutical intervention, which is an important elem...

    Authors: Ai Ling Oh, Yi Jing Tan, Wan Choon Chong, Irene Yee Yew Chieng, Jaime Yoke May Chan, Boon Phiaw Kho, Mei Ing Theng and Crystal Sing Yee Tan
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:7
    Content type: Research Published on:

  22. The aim of the study was to investigate the common deficiencies observed in the Finished Pharmaceutical Product (FPP) section of generic product applications submitted to SAHPRA. The study was conducted retros...

    Authors: Lerato Moeti, Madira Litedu and Jacques Joubert
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:6
    Content type: Research Published on:

  23. Vaccines have become the best weapon for epidemic prevention and control in the absence of standard approved effective therapies. However, skepticism about the vaccine efficacy and safety is constantly reporte...

    Authors: Philippe Hanna, Aline Issa, Ziad Noujeim, Mira Hleyhel and Nadine Saleh
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:5
    Content type: Research Published on:

  24. During the early phase of the COVID-19 pandemic, antibiotic usage among COVID-19 patients was noted to be high in many countries. The objective of this study was to determine the prevalence of antibiotic usage...

    Authors: Izzati-Nadhirah Mohamad, Calvin Ke-Wen Wong, Chii-Chii Chew, E-Li Leong, Biing-Horng Lee, Cheng-Keat Moh, Komalah Chenasammy, Steven Chee-Loon Lim and Hong-Bee Ker
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:4
    Content type: Research Published on:

  25. Substandard and Falsified (SF) medical products are a growing global concern. They harm the individual patient, the healthcare system and the economy. The World Health Organisation (WHO) has highlighted contri...

    Authors: R. J. Moshoeshoe, G. M. Enslin and D. R. Katerere
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:3
    Content type: Research Published on:

  26. Globally, an estimated 8.1 million children under 5 years die annually in developing countries. Ensuring essential medicines are accessible and affordable to the population is key to saving lives. This study i...

    Authors: Shannice Mahadeo, Keshmika Narain, Lungelo Mhlongo, Desmaine Chetty, Lindelani Masondo, Mandla Zungu, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:2
    Content type: Research Published on:

  27. Polypharmacy is the administration of an excessive number of medicines and a significant irrational medicine use practice. Little is known about this practice in South Africa. This study aimed to determine the...

    Authors: Adetola Olaniyi Bojuwoye, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2022 15:1
    Content type: Research Published on:

  28. During disasters or crises, the traditional models of supply chain encounter failure and skewedness under the inevitable and unknown pressures. The procurement and transformation of required equipment to the i...

    Authors: Peivand Bastani, Omid Sadeghkhani, Ramin Ravangard, Rita Rezaei, Parisa Bikine and Gholamhossein Mehralian
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:115
    Content type: Research Published on:

  29. Variations in practice are commonplace in healthcare where health professionals, such as pharmacists act as autonomous practitioners. This is evident in simulated patient studies, where pharmacists practice do...

    Authors: Deanna Mill, Jacinta L. Johnson, Kenneth Lee, Sandra M. Salter, Danielle D’Lima, Liza Seubert, Rhonda Clifford and Amy T. Page
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:114
    Content type: Research Published on:

  30. The proportion of days covered (PDC) is used to estimate medication adherence by looking at the proportion of days in which a person has access to the medication, over a given period of interest. This study ai...

    Authors: David Prieto-Merino, Amy Mulick, Craig Armstrong, Helen Hoult, Scott Fawcett, Lina Eliasson and Sarah Clifford
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:113
    Content type: Research Published on:

  31. The Commonwealth Pharmacists Association (CPA) is a charity representing pharmacists across the Commonwealth, with the vision of empowering and collaboratively develop the profession and fully utilise the pote...

    Authors: Ayesha Iqbal, Victoria Rutter, Gizem Gülpınar, Manjula Halai, Briella Awele, Rasha Abdelsalam Elshenawy, Claire Anderson, Rabia Hussain and Amy Hai Yan Chan
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:112
    Content type: Research Published on:

  32. Community pharmacists (CPs) are increasingly facing occupational challenges as a result of the COVID-19 pandemic, putting them at high risk of burnout. This study aimed to assess the prevalence of burnout amon...

    Authors: Dalal Youssef, Janet Youssef, Hamad Hassan and Linda Abou-Abbas
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:111
    Content type: Research Published on:

  33. While having access to safe and efficient vaccines is essential for eradicating the COVID-19 pandemic, gaining marketing authorisation is a critical step in enabling and speeding this process. On December 2, 2...

    Authors: Nasir Abbas and Zaheer-Ud-Din Babar
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:110
    Content type: Commentary Published on:

  34. Clinical pharmacists have an important role in inter-professional healthcare collaboration for epilepsy management. However, the pharmacy practices of managing epilepsy are still limited in Vietnam, deterring ...

    Authors: Hong Tham Pham, Minh-Hoang Tran, Ngoc Quy Nguyen, Van Tan Vo and Manh Hung Tran
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:109
    Content type: Research Published on:

  35. Access to maternal healthcare services is an essential pre-requisite for improving women’s health. However, due to poor access and underutilization, women in developing countries remain vulnerable to various c...

    Authors: Madeeha Malik, Katherine Prescott, Maliha Khalid, Ayisha Hashmi and Ayyaz Kiani
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:108
    Content type: Research Published on:

  36. Self-medication of medicines is a global issue particularly among those with good access and familiarity with medications such as university students. It has a significant impact on drug resistance and medicat...

    Authors: Getahun Fetensa, Tadesse Tolossa, Werku Etafa and Ginenus Fekadu
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:107
    Content type: Review Published on:

  37. There are limited studies on the role of efficient regulatory mechanisms in facilitating greater access to Hepatitis C virus (HCV) treatment. Evidence to support the importance of effective pharmaceutical poli...

    Authors: Mahmoud H. Teaima, Adi Al-Nuseirat, Dalia Abouhussein, Osama A. Badary and Mohamed A. El-Nabarawi
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:106
    Content type: Review Published on:

  38. The standard treatment guidelines (STGs) and essential medicines list (EML) were a policy option recommended in the National Drug Policy for South Africa in 1996 to address the irrational and bloated medicines...

    Authors: Tashni Govender, Fatima Suleman and Velisha Ann Perumal-Pillay
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:105
    Content type: Research Published on:

  39. Alleviating acute and chronic pain is a moral imperative for health professionals and health systems, and it requires adequate access to and use of essential opioid analgesics. However, this is still a neglect...

    Authors: Serena Frau, Anselme Mubeneshayi Kananga, Jackie Ndona Kingolo, Ghislaine Mbelu Kanyunyu, André Katele H. Zongwe, Aaron Nshindi Tshilengi and Raffaella Ravinetto
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:104
    Content type: Short report Published on:

  40. In Lebanon, the role of the pharmacist remains underestimated in the medication reconciliation process, especially in surgical departments. This study aims to assess the impact of pharmacist-conducted medicati...

    Authors: Ahmad El Ouweini, Lamis R. Karaoui, Nibal Chamoun, Chahine Assi, Kaissar Yammine and Elsy Ramia
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:103
    Content type: Research Published on:

  41. With the outbreak of Coronavirus infection (COVID-19), pharmacists play an important role in supporting local health during this emergency.

    Authors: Iman A. Basheti, Nizar M. Mhaidat, Sayer Al-Azzam, Rajaa Alqudah, Razan Nassar, Hamzah Alzubaidi, Mahmoud S. Abu-Samak and Eman Abu-Gharbieh
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:102
    Content type: Research Published on:

  42. The Department of Health and Human Services and the Food and Drug Administration released the Safe Importation Action Plan in July 2020 detailing methods to import medicines from Canada to combat increasing dr...

    Authors: John B. Hertig, Jade M. Jochem and Allissa M. Long
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:101
    Content type: Research Published on:

  43. Therapeutic drug monitoring (TDM) of Vancomycin (VCM) is required to prevent inappropriate dosage-associated bacterial resistance, therapeutic failure, and toxicities in pediatrics. Anecdotal experience and st...

    Authors: Kashif Hussain, Rahila Ikram, Gul Ambreen and Muhammad Sohail Salat
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:100
    Content type: Research Published on:

  45. Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can l...

    Authors: Ali Elbeddini, Anthony To, Yasamin Tayefehchamani and Cindy Xin Wen
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14:98
    Content type: Commentary Published on:

  47. Indonesia is the second country with the highest number of malaria cases in Southeast Asia. Private health providers including community pharmacies often become the first point of care for the population seeki...

    Authors: Astri Ferdiana, Utsamani Cintyamena, Luthfi Azizatunnisa’, Edi Sunandar and Ari Probandari
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):90
    Content type: Research Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  48. The role of community drug shops in providing primary care has been recognized as important in Myanmar as in other countries. The contribution by private community drug shops to National Tuberculosis case noti...

    Authors: May Me Thet, Myat Noe Thiri Khaing, Su Su Zin, Sandar Oo, Ye Kyaw Aung and Si Thu Thein
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):89
    Content type: Research Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

  50. The National Drug Policy in Bangladesh prohibits the sale and distribution of antibiotics without prescription from a registered physician. Compliance with this policy is poor; prescribing antibiotics by unqua...

    Authors: Fosiul Alam Nizame, Dewan Muhammad Shoaib, Emily K. Rousham, Salma Akter, Mohammad Aminul Islam, Afsana Alamgir Khan, Mahbubur Rahman and Leanne Unicomb
    Citation: Journal of Pharmaceutical Policy and Practice 2021 14(Suppl 1):85
    Content type: Research Published on:

    This article is part of a Supplement: Volume 14 Supplement 1

Submit manuscript

Follow

Annual Journal Metrics

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us